Feld, Jordan J.

Publishing since 2002 (Junior)

Has published 23 publications in 9 years

Number of publications published per year by Feld, Jordan J.. (Source : PubMed)

Distribution of publications types for Feld, Jordan J.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Feld JJ, Lutchman GA, Heller T, Hara K, Pfeiffer JK, Leff RD, Meek C, Rivera M, Ko M, Koh C, Rotman Y, Ghany MG, Haynes-Williams V, Neumann AU, Liang TJ, Hoofnagle JH. Ribavirin improves early responses to peginterferon through enhanced interferon signaling. Gastroenterology 2010
Rotman Y, Borg BB, Soza A, Feld JJ, Modi AA, Loomba R, Lutchman G, Rivera E, Doo E, Ghany MG, Heller T, Neumann AU, Liang TJ, Hoofnagle JH. Clinical trial: low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3 - efficacy, tolerability, viral kinetics and cytokine response. Aliment. Pharmacol. Ther. 2010
Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, Hoofnagle JH. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010;51;1
Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y, Ghany MG, Hoofnagle JH, Liang TJ, Heller T, Rehermann B. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 2010;138;1
Palmore TN, Shah NL, Loomba R, Borg BB, Lopatin U, Feld JJ, Khokhar F, Lutchman G, Kleiner DE, Young NS, Childs R, Barrett AJ, Liang TJ, Hoofnagle JH, Heller T. Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression. Clin. Gastroenterol. Hepatol. 2009;7;10
Feld JJ, Wong DK, Heathcote EJ. Endpoints of therapy in chronic hepatitis B. Hepatology 2009;49;5 Suppl
Loomba R, Lutchman G, Kleiner DE, Ricks M, Feld JJ, Borg BB, Modi A, Nagabhyru P, Sumner AE, Liang TJ, Hoofnagle JH. Clinical trial: Pilot study of metformin for the treatment of nonalcoholic steatohepatitis. Aliment. Pharmacol. Ther. 2008
O'Brien C, Joshi S, Feld JJ, Guindi M, Dienes HP, Heathcote EJ. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 2008;48;2
Feld JJ, Hussain N, Wright EC, Kleiner DE, Hoofnagle JH, Ahlawat S, Anderson V, Hilligoss D, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology 2008;134;7
Feld JJ, Ghany MG. Evolution of therapy for chronic hepatitis B: progressing from the simple to the complex. Ann. Intern. Med. 2007;147;11

[ See timeline ] [ See all publications ]

h=12

means that Feld, Jordan J. has 12 papers cited a least 12 times - methodology

Key figures

23 pub in 9 years
2.6 publications/year
best year 2007 with 7 pub
h-index 12 with 23 pub
h-ratio : 52 %

See Timeline

Ranking

It's me !

Click here if you are
Feld, Jordan J..

Most frequent Journals

Hepatology (9x)
Gastroenterology (4x)
Aliment. Pharmacol. Ther. (2x)
J. Gastroenterol. Hepatol. (1x)
Antiviral Res. (1x)

Main affiliation

Immunology Section, National Institute for Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892-1800, USA.

Latest co-workers

Ahlawat S Anderson V Fried MW Gallin JI Ghany MG Guindi M Heathcote EJ Heller T Hilligoss D Holland SM Hoofnagle JH Huang Y Hussain N Kleiner DE Koh C Liang TJ Malech HL Modi AA Nanda S Rotman Y

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.